talaumidin and Retinal-Degeneration

talaumidin has been researched along with Retinal-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for talaumidin and Retinal-Degeneration

ArticleYear
Talaumidin Promotes Neurite Outgrowth of Staurosporine-Differentiated RGC-5 Cells Through PI3K/Akt-Dependent Pathways.
    Advances in experimental medicine and biology, 2018, Volume: 1074

    Talaumidin, a tetrahydrofuran neolignan isolated from the root of Aristolochia arcuata, was an interesting small molecule with neurotrophic activity in the cultured neuron. Talaumidin can promote neurite outgrowth from neurons. However, the mechanism by which talaumidin exerts its neurotrophic actions on retinal neurons has not been elucidated to date. In this study, we describe that talaumidin has neurotrophic properties such as neurite outgrowth in neuroretinal cell line, RGC-5. Talaumidin promotes staurosporine-induced neurite outgrowth in RGC-5 cells. The neurite outgrowth effect of talaumidin was inhibited by phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, but not by Erk inhibitor, PD98059. These data suggest that talaumidin promotes neurite outgrowth through PI3K/Akt pathway and that the potential of talaumidin serves as a promising lead compound for the treatment of retinal degenerative disorders.

    Topics: Animals; Cell Differentiation; Cell Line; Chromones; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Furans; Mice; Morpholines; Neuronal Outgrowth; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phytotherapy; Plant Extracts; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Retinal Degeneration; Retinal Ganglion Cells; Signal Transduction; Staurosporine

2018